Fundraising Fox

Apriori Bio

22 employees on LinkedIn · 2 known investors

Apriori Bio applies AI/ML combined with biological insights to predict how viruses evolve and to design vaccines, assessing their expected performance before clinical trials. The company operates in the vaccinology and biotech space.

AI & Machine LearningBiotechDeep TechHealthtech

Investors · 2

Flagship Pioneering✓ verifiedCambridge · $500K – $10M

Also in the syndicate · 1

CEPI

Funding

SEC filings, press & company announcements

$1.1M disclosed across 1 round · 2024

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

2 people who came through Apriori Bio went on to found or lead other companies.

Noubar AfeyanCo-Founder and ChairmanFounded ProFound Therapeutics +12Lovisa AfzeliusFounding CEO & Chair of the BoardFounded AllTrna +1

In the news

Flagship-backed Apriori Bio lays off employees, shifts focus to pipeline developmentfiercebiotech.com · Mar 2025Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori Bioprnewswire.com · Nov 2024Apriori Bio Raises $1.1M Funding | citybizcitybiz.co · Jul 2024MA-based Apriori Bio Raises $1.1M Funding from CEPIstartuprise.io · Jul 2024Flagship-backed startup Apriori Bio aims to 'close off the escape routes' for evolving viruses - Boston Business Journalbizjournals.com · Jul 2022

Frequently asked questions

What does Apriori Bio do?
Apriori Bio applies AI/ML combined with biological insights to predict how viruses evolve and to design vaccines, assessing their expected performance before clinical trials. The company operates in the vaccinology and biotech space.
Who are Apriori Bio's investors?
Apriori Bio's investors include Flagship Pioneering.
How much funding has Apriori Bio raised?
Apriori Bio has disclosed $1.1M raised across 1 round.